Abstract
Despite aggressive multimodal strategies, the prognosis in patients affected by primary brain tumors is still very unfavorable. Glial tumors seem to be able to create a favorable environment for the invasion of neoplastic cells into the cerebral parenchyma when they interact with the extracellular matrix via cell surface receptors. The major problem in drug delivery into the brain is due to the presence of the blood brain barrier which limits drug penetration. Nanotechnology involves the design, synthesis and characterization of materials that have a functional organization at least in one dimension on the nanometer scale. Nanoengineered devices in medical applications are designed to interface and interact with cells and tissues at the molecular level. Nanoparticle systems can represent ideal devices for delivery of specific compounds to brain tumors, across the blood brain barrier. In this brief review, we report the results of studies related to the emerging novel applications of nanoparticle systems in diagnosis and treatment of primary brain tumors, and also the patents of studies that adopt nanoparticle systems as drug delivery carriers in brain tumor diagnosis and therapy.
Keywords: Drug delivery, nanoparticles, nanotechnology, primary brain tumors
Recent Patents on Nanotechnology
Title: Nanotechnology Platforms in Diagnosis and Treatment of Primary Brain Tumors
Volume: 4 Issue: 2
Author(s): Gerardo Caruso, Giuseppe Raudino, Mariella Caffo, Concetta Alafaci, Francesca Granata, Sebastiano Lucerna, Francesco M. Salpietro and Francesco Tomasello
Affiliation:
Keywords: Drug delivery, nanoparticles, nanotechnology, primary brain tumors
Abstract: Despite aggressive multimodal strategies, the prognosis in patients affected by primary brain tumors is still very unfavorable. Glial tumors seem to be able to create a favorable environment for the invasion of neoplastic cells into the cerebral parenchyma when they interact with the extracellular matrix via cell surface receptors. The major problem in drug delivery into the brain is due to the presence of the blood brain barrier which limits drug penetration. Nanotechnology involves the design, synthesis and characterization of materials that have a functional organization at least in one dimension on the nanometer scale. Nanoengineered devices in medical applications are designed to interface and interact with cells and tissues at the molecular level. Nanoparticle systems can represent ideal devices for delivery of specific compounds to brain tumors, across the blood brain barrier. In this brief review, we report the results of studies related to the emerging novel applications of nanoparticle systems in diagnosis and treatment of primary brain tumors, and also the patents of studies that adopt nanoparticle systems as drug delivery carriers in brain tumor diagnosis and therapy.
Export Options
About this article
Cite this article as:
Caruso Gerardo, Raudino Giuseppe, Caffo Mariella, Alafaci Concetta, Granata Francesca, Lucerna Sebastiano, M. Salpietro Francesco and Tomasello Francesco, Nanotechnology Platforms in Diagnosis and Treatment of Primary Brain Tumors, Recent Patents on Nanotechnology 2010; 4 (2) . https://dx.doi.org/10.2174/187221010791208786
DOI https://dx.doi.org/10.2174/187221010791208786 |
Print ISSN 1872-2105 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4020 |
Call for Papers in Thematic Issues
Advances in Vanadium and Titanium Resources for High-performance Materials via Nanostructuring and Nanoengineering (updated BMS-NANOTEC-2023-HT-31)
Vanadium and titanium-based materials are ideal candidates for structural and functional materials in aerospace, biomedical engineering, optics, catalysis, energy storage and conversion etc. Vanadium/titanium-based alloys, compounds and materials have a large family with different chemical compositions, dimensions, structures/morphologies, and chemical/physical/mechanical properties, which provides huge opportunities for the development of emerging ...read more
Endogenous- and exogenous-responsive nanocarriers for disease theranostics
Smart nanoplatforms with endogenous- and exogenous-responsiveness have been developed in biomedical applications, such as pH, redox, enzyme, hypoxia, light, ultrasound, radiation, electricity, magnetism, heat, etc. These smart nanocarriers can be effectively delivered by overcoming various barriers in vivo and achieve stimuli-responsive drug/gene release in targeted tissues, thus realizing the enhanced ...read more
Nanotechnology Emphasis on Novel Multifunctional Nanomaterials and Advanced Manufacturing for Applications in Science and Engineering
Nanotechnology and material science play key roles in the intrinsically multidisciplinary subject of Multifunctional Nanomaterials, Advanced Manufacturing, and Interfaces. Because of their unique qualities, these materials—which set them apart from their bulk counterparts—find use in a variety of industries, including aerospace, automotive, electronics, medical, energy, and materials engineering. They have ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Dynamic Contrast-Enhanced MRI in Oncology Drug Development
Current Clinical Pharmacology The HGF-Met Signaling Axis: Emerging Themes and Targets of Inhibition
Current Protein & Peptide Science Summary of Information on the Effects of Ionizing and Non-ionizing Radiation on Cytochrome P450 and Other Drug Metabolizing Enzymes and Transporters
Current Drug Metabolism Mutations in MicroRNA Genes and Their Binding Sites are Infrequently Associated with Human Colorectal Cancer in the Kashmiri Population
MicroRNA Cadmium-containing Quantum Dots: Current Perspectives on Their Application as Nanomedicine and Toxicity Concerns
Mini-Reviews in Medicinal Chemistry Factors that Control the Circulation Time of Nanoparticles in Blood: Challenges, Solutions and Future Prospects
Current Pharmaceutical Design Image Fusion of Diagnostic Ultrasound with Other Modalities
Current Medical Imaging Cervical Cancer Diagnosis: Insights into Biochemical Biomarkers and Imaging Techniques
Combinatorial Chemistry & High Throughput Screening Exploring the Nucleolar Proteome: Novel Concepts for Chaperone Trafficking and Function
Current Proteomics MicroRNAs-Based Therapeutic Strategy for Virally Induced Diseases
Current Drug Discovery Technologies Curcumin: Not So Spicy After All
Mini-Reviews in Medicinal Chemistry Antileukemic Properties of Sesquiterpene Lactones: A Systematic Review
Anti-Cancer Agents in Medicinal Chemistry Cellular Retinoic-Acid Binding Protein 2 in Solid Tumor
Current Protein & Peptide Science The Role of Melanocortin Peptides and Receptors in Regulation of Energy Balance
Current Pharmaceutical Design Non-Camptothecin DNA Topoisomerase I Inhibitors in Cancer Therapy
Current Topics in Medicinal Chemistry Combined Treatment with JFKD and Gefitinib Overcomes Drug Resistance in Non-Small Cell Lung Cancer
Current Pharmaceutical Biotechnology A Synopsis of Nano-Technological Approaches Toward Anti-Epilepsy Therapy: Present and Future Research Implications
Current Drug Metabolism Glia: An Important Target for Anti-Inflammatory and Antidepressant Activity
Current Drug Targets EGFR-Targeted Therapy in Malignant Glioma: Novel Aspects and Mechanisms of Drug Resistance
Current Molecular Pharmacology Dry Age-Related Macular Degeneration: Recent Progress of Therapeutic approaches
Current Molecular Pharmacology